[BOMP (BLM, VCR, MMC, and CDDP) therapy for advanced cervical cancer].
Katayama
Hideto
H
Department of Obstetrics & Gynecology, Asahikawa Medical College.
Yamashita
Tsuyoshi
T
Sengoku
Kazuo
K
Ishikawa
Mutsuo
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced; D016685:Mitomycin / Q000008:administration & dosage / Q000009:adverse effects; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009367:Neoplasm Staging; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
D001761:Bleomycin; D016685:Mitomycin; D014750:Vincristine; D002945:Cisplatin